Dowdy DW - Search Results

1

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.

Kendall EA, Fojo AT, Dowdy DW. Kendall EA, et al. Among authors: dowdy dw. Lancet Respir Med. 2017 Mar;5(3):191-199. doi: 10.1016/S2213-2600(16)30423-4. Epub 2016 Dec 16. Lancet Respir Med. 2017. PMID: 27989591 Free PMC article.

2

Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis.

Dowdy DW, Basu S, Andrews JR. Dowdy DW, et al. Am J Respir Crit Care Med. 2013 Mar 1;187(5):543-51. doi: 10.1164/rccm.201207-1217OC. Epub 2012 Dec 21. Am J Respir Crit Care Med. 2013. PMID: 23262515 Free PMC article.

3

Cost-effectiveness of novel first-line treatment regimens for tuberculosis.

Owens JP, Fofana MO, Dowdy DW. Owens JP, et al. Among authors: dowdy dw. Int J Tuberc Lung Dis. 2013 May;17(5):590-6. doi: 10.5588/ijtld.12.0776. Int J Tuberc Lung Dis. 2013. PMID: 23575322 Free PMC article.

4

Population-level impact of active tuberculosis case finding in an Asian megacity.

Dowdy DW, Lotia I, Azman AS, Creswell J, Sahu S, Khan AJ. Dowdy DW, et al. PLoS One. 2013 Oct 16;8(10):e77517. doi: 10.1371/journal.pone.0077517. eCollection 2013. PLoS One. 2013. PMID: 24147015 Free PMC article.

5

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.

Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K; TB-NEAT team. Theron G, et al. Lancet. 2014 Feb 1;383(9915):424-35. doi: 10.1016/S0140-6736(13)62073-5. Epub 2013 Oct 28. Lancet. 2014. PMID: 24176144 Clinical Trial.

6

Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?

Denkinger CM, Pai M, Dowdy DW. Denkinger CM, et al. Among authors: dowdy dw. PLoS One. 2014 Jan 3;9(1):e84197. doi: 10.1371/journal.pone.0084197. eCollection 2014. PLoS One. 2014. PMID: 24404155 Free PMC article.

7

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K. Theron G, et al. Lancet Infect Dis. 2014 Jun;14(6):527-32. doi: 10.1016/S1473-3099(13)70360-8. Epub 2014 Jan 15. Lancet Infect Dis. 2014. PMID: 24438820

8

Tuberculosis: progress and challenges in product development and delivery.

Pai M, Dowdy D. Pai M, et al. Lancet Respir Med. 2014 Jan;2(1):25-7. doi: 10.1016/S2213-2600(13)70256-X. Epub 2013 Dec 23. Lancet Respir Med. 2014. PMID: 24461893 No abstract available.

9

Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.

Fofana MO, Knight GM, Gomez GB, White RG, Dowdy DW. Fofana MO, et al. Among authors: dowdy dw. PLoS One. 2014 May 9;9(5):e96389. doi: 10.1371/journal.pone.0096389. eCollection 2014. PLoS One. 2014. PMID: 24816692 Free PMC article.

10

Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Dowdy DW, et al. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):552-8. doi: 10.1097/QAI.0000000000000219. J Acquir Immune Defic Syndr. 2014. PMID: 24853308 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters